Game Creek Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Game Creek Capital's REGN Position: Q2 2026 in Review
Game Creek Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 51% in Q2 2026, selling an estimated $1.91M and leaving 2,725 shares worth $1.7M. The position accounts for 0.6% of the portfolio, ranked #49.
Game Creek Capital first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.51M in Q4 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Game Creek Capital held 2,725 shares of Regeneron Pharmaceuticals worth $1.7M as of Q2 2026.
- Game Creek Capital sold 2,800 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.91M.
- Regeneron Pharmaceuticals made up 0.6% of Game Creek Capital's portfolio in Q2 2026, its #49 holding.
- Game Creek Capital first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- Game Creek Capital's Regeneron Pharmaceuticals position peaked at $6.51M in Q4 2025.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Game Creek Capital's 13F filing for Q2 2026, filed 13 Aug 2026.